Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: Temporal trends and timing of amniocentesis in pregnancy

Environmental Health Perspectives

Volumn 120, Issue 6, 2012, Pages 897-903

  Jensen, Morten Sondergaard ^a   Norgaard Pedersen, Bent ^b   Toft, Gunnar ^a   Hougaard, David M ^b   Bonde, Jens Peter ^c   Cohen, Arieh ^b   Thulstrup, Ane Marie ^a   Ivell, Richard ^d   Anand Ivell, Ravinder ^d   Lindh, Christian H ^e   Jönsson, Bo A G ^e  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^e LUND UNIVERSITY   (Sweden)

Author keywords

Amniocentesis; Amniotic fluid; Biobank; Biomonitoring; Perfluorinated compounds; Phthalates; Pregnancy; Temporal trend

Indexed keywords

COTININE; PERFLUOROOCTANESULFONIC ACID; PHTHALIC ACID; PHTHALIC ACID BIS (2 ETHYLHEXYL) ESTER; PHTHALIC ACID DIISONONYL ESTER; UNCLASSIFIED DRUG;

ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MATERNAL AGE; PARITY; PREGNANT WOMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL;

ALKANESULFONIC ACIDS; AMNIOCENTESIS; AMNIOTIC FLUID; CHROMATOGRAPHY, LIQUID; DENMARK; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; GESTATIONAL AGE; HUMANS; LINEAR MODELS; MALE; MASS SPECTROMETRY; MATERNAL EXPOSURE; PHTHALIC ACIDS; PREGNANCY;

EID: 84862012958     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104522     Document Type: Article

References (52)

1. Adibi JJ, Perera FP, Jedrychowski W, Camann DE, Barr D, Jacek R, et al. 2003. Prenatal exposures to phthalates among women in New York City and Krakow, Poland. Environ Health Perspect 111:1719-1722.
2. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, OlsenJH. 1999. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263-268.
3. Arbuckle TE. 2010. Maternal-infant biomonitoring of environmental chemicals: the epidemiologic challenges. Birth Defects Res A Clin Mol Teratol 88:931-937.
4. Benzie RJ, Doran TA, Harkins JL, Owen VM, Porter CJ. 1974. Composition of the amniotic fluid and maternal serum in pregnancy. Am J Obstet Gynecol 119:798-810.
5. Brace RA. 1997. Physiology of amniotic fluid volume regulation. Clin Obstet Gynecol 40:280-289.
6. Calafat AM, Brock JW, Silva MJ, Gray LE Jr, Reidy JA, Barr DB, et al. 2006. Urinary and amniotic fluid levels of phthalate monoesters in rats after the oral administration of di(2-ethylhexyl) phthalate and di-n-butyl phthalate. Toxicology 217:22-30.
7. Chen JA, Liu H, Qiu Z, Shu W. 2008. Analysis of di-n-butyl phthalate and other organic pollutants in Chongqing women undergoing parturition. Environ Pollut 156:849-853.
8. Consortium to Perform Human Biomonitoring on a European Scale (COPHES). 2012. Homepage. Available: http://www.eu-hbm.info/cophes [accessed 1April 2012].
9. Fei C, McLaughlin JK, Lipworth L, Olsen J. 2009. Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 24:1200-1205.
10. Fromme H, Mosch C, Morovitz M, Alba-Alejandre I, Boehmer S, Kiranoglu M, et al. 2010. Pre-and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol 44:7123-7129.
11. Fromme H, Tittlemier SA, Volkel W, Wilhelm M, Twardella D. 2009. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int J Hyg Environ Health 212:239-270.
12. Gilbert WM, Brace RA. 1993. Amniotic fluid volume and normal flows to and from the amniotic cavity. Semin Perinatol 17:150-157.
13. Griffiths WC, Camara PD, Saritelli A, Gentile J. 1988. The in vitro serum protein-binding characteristics of bis-(2-ethylhexyl) phthalate and its principal metabolite, mono-(2-ethylhexyl) phthalate. Environ Health Perspect 77:151-156.
14. Hanssen L, Rollin H, Odland JO, Moe MK, Sandanger TM. 2010. Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: results of a pilot study. J Environ Monit 12:1355-1361.
15. Harada K, Inoue K, Morikawa A, Yoshinaga T, Saito N, Koizumi A. 2005. Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 99:253-261.
16. Haug LS, Thomsen C, Becher G. 2009. Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. Environ Sci Technol 43:2131-2136.
17. Heudorf U, Mersch-Sundermann V, Angerer J. 2007. Phthalates: toxicology and exposure. Int J Hyg Environ Health 210:623-634.
18. Huang PC, Kuo PL, Chou YY, Lin SJ, Lee CC. 2009. Association between prenatal exposure to phthalates and the health of newborns. Environ Int 35:14-20.
19. Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, et al. 2004. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112:1204-1207.
20. Jauniaux E, Gulbis B, Acharya G, Thiry P, Rodeck C. 1999. Maternal tobacco exposure and cotinine levels in fetal fluids in the first half of pregnancy. Obstet Gynecol 93:25-29.
21. Jauniaux E, Gulbis B, Jurkovic D, Campbell S, Collins WP, OomsHA. 1994. Relationship between protein concentrations in embryological fluids and maternal serum and yolk sac size during human early pregnancy. Hum Reprod 9:161-166.
22. Jones PD, Hu W, De Coen W, Newsted JL, Giesy JP. 2003. Binding of perfluorinated fatty acids to serum proteins. Environ Toxicol Chem 22:2639-2649.
23. Jørgensen FS. 1999. Epidemiological studies of obstetric ultrasound examinations in Denmark 1989-1990 versus 1994-1995. Acta Obstet Gynecol Scand 78:305-309.
24. Jurewicz J, Hanke W. 2011. Exposure to phthalates: reproductive outcome and children health. A review of epidemiological studies. Int J Occup Med Environ Health 24:115-141.
25. Knudsen LB, Olsen J. 1998. The Danish Medical Birth Registry. Dan Med Bull 45:320-323.
26. Kudo N, Kawashima Y. 2003. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J Toxicol Sci 28:49-57.
27. Latini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, et al. 2003. Exposure to di(2-ethylhexyl)phthalate in humans during pregnancy. A preliminary report. Biol Neonate 83:22-24.
28. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J. 2007. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366-394.
29. Lau C, Butenhoff JL, Rogers JM. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198:231-241.
30. Lotgering FK, Wallenburg HC. 1986. Mechanisms of production and clearance of amniotic fluid. Semin Perinatol 10:94-102.
31. Matsumoto M, Hirata-Koizumi M, Ema M. 2008. Potential adverse effects of phthalic acid esters on human health: a review of recent studies on reproduction. Regul Toxicol Pharmacol 50:37-49.
32. Modena AB, Fieni S. 2004. Amniotic fluid dynamics. Acta Biomed 75(suppl 1):11-13.
33. Monroy R, Morrison K, Teo K, Atkinson S, Kubwabo C, StewartB, et al. 2008. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 108:56-62.
34. Mose T, Knudsen LE, Hedegaard M, Mortensen GK. 2007a. Transplacental transfer of monomethyl phthalate and mono(2-ethylhexyl) phthalate in a human placenta perfusion system. Int J Toxicol 26:221-229.
35. Mose T, Mortensen GK, Hedegaard M, Knudsen LE. 2007b. Phthalate monoesters in perfusate from a dual placenta perfusion system, the placenta tissue and umbilical cord blood. Reprod Toxicol 23:83-91.
36. Olsen GW, Butenhoff JL, Zobel LR. 2009. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol 27:212-230.
37. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. 2006. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 53:441-449.
38. Queenan JT. 1978. Amniotic fluid proteins, amniotic fluid amino acids and their clinical significance. In: Amniotic Fluid-Research and Clinical Application (Fairweather D, Eskes T, eds). 2nd rev. ed. Amsterdam:Excerpta Medica, 187-208.
39. Sibai BM, Frangieh A. 1995. Maternal adaptation to pregnancy. Curr Opin Obstet Gynecol 7:420-426.
40. Silva MJ, Reidy JA, Herbert AR, Preau JL Jr, Needham LL, Calafat AM. 2004. Detection of phthalate metabolites in human amniotic fluid. Bull Environ Contam Toxicol 72:1226-1231.
41. Silva MJ, Reidy JA, Preau JL, Samandar E, Needham LL, Calafat AM. 2006. Measurement of eight urinary metabolites of di(2-ethylhexyl) phthalate as biomarkers for human exposure assessment. Biomarkers 11:1-13.
42. Wiesmuller GA, Eckard R, Dobler L, Gunsel A, OganowskiM, Schroter-Kermani C, et al. 2007. The Environmental Specimen Bank for Human Tissues as part of the German Environmental Specimen Bank. Int J Hyg Environ Health 210:299-305.
43. Wilhelm M, Holzer J, Dobler L, Rauchfuss K, Midasch O, KraftM, et al. 2009. Preliminary observations on perfluorinated compounds in plasma samples (1977-2004) of young German adults from an area with perfluorooctanoate-contaminated drinking water. Int J Hyg Environ Health 212:142-145.
44. Wittassek M, Angerer J. 2008. Phthalates: metabolism and exposure. Int J Androl 31:131-138.
45. Wittassek M, Angerer J, Kolossa-Gehring M, Schafer SD, Klockenbusch W, Dobler L, et al. 2009. Fetal exposure to phthalates-a pilot study. Int J Hyg Environ Health 212:492-498.
46. Wittassek M, Wiesmuller GA, Koch HM, Eckard R, Dobler L, Muller J, et al. 2007. Internal phthalate exposure over the last two decades-a retrospective human biomonitoring study. Int J Hyg Environ Health 210:319-333.
47. Woodruff TJ, Zota AR, Schwartz JM. 2011. Environmental chemicals in pregnant women in the United States: NHANES 2003-2004. Environ Health Perspect 119:878-885.
48. World Health Organization. 1969. International Classification of Diseases, 8th Revision. Geneva:World Health Organization.
49. World Health Organization. 1993. International Classification of Diseases, 10th Revision. Geneva:World Health Organization.
50. Yan X, Calafat A, Lashley S, Smulian J, Ananth C, Barr D, et al. 2009. Phthalates biomarker identification and exposure estimates in a population of pregnant women. Hum Ecol Risk Assess 15:565-578.
51. Yu WG, Liu W, Jin YH, Liu XH, Wang FQ, Liu L, et al. 2009. Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system. Environ Sci Technol 43:8416-8422.
52. Zhang Y, Lin L, Cao Y, Chen B, Zheng L, Ge RS. 2009. Phthalate levels and low birth weight: a nested case-control study of Chinese newborns. J Pediatr 155:500-504.